日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Successful treatment of refractory cold agglutinin syndrome using fixed-duration daratumumab, bortezomib and dexamethasone with a sutimlimab bridge

使用固定疗程的达雷妥尤单抗、硼替佐米和地塞米松联合舒替利单抗桥接治疗,成功治愈难治性冷凝集素综合征。

Rybinski, Brad; James, Miranda; Hardy, Nancy; Koka, Rima; Rapoport, Aaron P

Farletuzumab ecteribulin and MORAb-109, folate receptor alpha and mesothelin targeting antibody-drug conjugates, show activity in poor prognosis gynaecological cancer models

法利妥珠单抗(Farletuzumab ecteribulin)和 MORAb-109 是靶向叶酸受体 α 和间皮素的抗体药物偶联物,在预后不良的妇科癌症模型中显示出活性。

Nesic, Ksenija; Rybinski, Katherine; Ratnayake, Gayanie; Ho, Gwo-Yaw; Lim, Ratana; Radke, Marc; Neagle, Chloe; Swisher, Elizabeth M; Wakefield, Matthew J; Barker, Holly E; Furuuchi, Keiji; Scott, Clare L; Vandenberg, Cassandra J

An Evaluation of Large Language Models for Supplementing a Food Extrusion Dataset

大型语言模型在补充食品挤压数据集方面的评估

Bölücü, Necva; Pennells, Jordan; Yang, Huichen; Rybinski, Maciej; Wan, Stephen

Preclinical studies of BB-1701, a HER2-targeting eribulin-containing ADC with potent bystander effect and ICD activity.

BB-1701 是一种靶向 HER2 的含艾立布林的抗体药物偶联物 (ADC),具有强大的旁观者效应和 ICD 活性,其临床前研究

Wang Yang, Xia Bing, Cao Lixia, Yang Jianfeng, Feng Cui, Jiang Fangdun, Li Chen, Gu Lixia, Yang Yifan, Tian Jing, Cheng Xin, Furuuchi Keiji, Fulmer James, Verdi Arielle, Rybinski Katherine, Soto Allis, Albone Earl, Uenaka Toshimitsu, Gong Likun, Liu Tingting, Qin Qiuping, Wei Ziping, Zhou Yuhong

Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era

延长来那度胺诱导治疗并不会显著影响使用环磷酰胺或普乐沙福动员的多发性骨髓瘤患者的干细胞采集:一项来自新冠疫情时代的报告

Rybinski, Brad; Rapoport, Aaron P; Badros, Ashraf Z; Hardy, Nancy; Kocoglu, Mehmet

Cancer stem cells, not bulk tumor cells, determine mechanisms of resistance to SMO inhibitors

癌症干细胞,而不是大量肿瘤细胞,决定了对 SMO 抑制剂的耐药机制

Joshy George, Yaohui Chen, Nourhan Abdelfattah, Keiko Yamamoto, Thomas D Gallup, Scott I Adamson, Brad Rybinski, Anuj Srivastava, Parveen Kumar, Min Gyu Lee, David S Baskin, Wen Jiang, Jong Min Choi, William Flavahan, Jeffrey H Chuang, Betty Ys Kim, Jiaqiong Xu, Sung Yun Jung, Kyuson Yun

Antibody-drug conjugate MORAb-202 exhibits long-lasting antitumor efficacy in TNBC PDx models

抗体药物偶联物 MORAb-202 在 TNBC PDx 模型中表现出持久的抗肿瘤疗效

Furuuchi, Keiji; Rybinski, Katherine; Fulmer, James; Moriyama, Tomoyuki; Drozdowski, Brian; Soto, Allis; Fernando, Shawn; Wilson, Kerrianne; Milinichik, Andrew; Dula, Mary Lou; Tanaka, Keigo; Cheng, Xin; Albone, Earl; Uenaka, Toshimitsu

Extracting Family History Information From Electronic Health Records: Natural Language Processing Analysis

从电子健康记录中提取家族史信息:自然语言处理分析

Rybinski, Maciej; Dai, Xiang; Singh, Sonit; Karimi, Sarvnaz; Nguyen, Anthony

Hepatic AL Amyloidosis without Significant Light Chain Elevation in a Patient Treated with CyBorD Plus Daratumumab

接受 CyBorD 联合 Daratumumab 治疗的患者出现肝脏 AL 淀粉样变性,但轻链水平未显著升高

Rybinski, Brad; Kocoglu, Mehmet

A2A: a platform for research in biomedical literature search

A2A:一个用于生物医学文献检索的研究平台

Rybinski, Maciej; Karimi, Sarvnaz; Nguyen, Vincent; Paris, Cecile